Please assess the completion status of the following clinical trial:

Trial Title: Cubicin(R) for Complicated Post-surgical Wound Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Read and signed informed consent form~* female of childbearing potential, negative pregnancy test result~* Confirmed diagnosis of post-surgical wound infections known or suspected (based on Gram stain) to be due to Gram-positive organisms obtained within 3 calendar days prior to first dose of study medication~* Onset of surgical wound infection within 30 days after surgery~* At least three clinical signs and symptoms of skin infection~Exclusion Criteria:~* previous systemic antimicrobial therapy exceeding 24 hours duration administered anytime during 72 hours prior to the first dose of study drug~* Uncomplicated surgical infections (eg, stitch abscesses)~* osteomyelitis, pneumonia, bacteremia, endocarditis, or urinary tract infection~* Any type of space infection~* Conditions requiring surgical removal of wound infection~* necrotizing fasciitis, synergistic gangrene, Clostridial myonecrosis (gas gangrene), or Fournier's gangrene;~* Foreign material involved in the post-surgical wound infection~* Known to be allergic or intolerant to study medication~* Creatinine Clearance (CLCR) \<30 mL/min~* history of neurological disease (eg, Guillain-Barré, multiple sclerosis)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).